Zevra Therapeutics, Inc. Common Stock (ZVRA) is a publicly traded Healthcare sector company. As of July 22, 2026, ZVRA trades at $12.14 with a market cap of $711.15M and a P/E ratio of 8.85. ZVRA moved -2.65% today. Year to date, ZVRA is +38.95%; over the trailing twelve months it is +6.14%. Its 52-week range spans $6.19 to $15.04. Analyst consensus is strong buy with an average price target of $28.25. Rallies surfaces ZVRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ZVRA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $12.14 |
| Market Cap | $711.15M |
| P/E Ratio | 8.85 |
| EPS | $1.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.04 |
| 52-Week Low | $6.19 |
| Volume | 277.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $106.47M |
| Net Income | $83.23M |
| Gross Margin | 0.00% |
9 analysts cover ZVRA: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $28.25.